Development of non-viral vehicles for targeted gene transfer into microglia via the integrin receptor CD11b

Por Smolny, Markus, Rogers, Mary-Louise, Shafton, Anthony, Rush, Robert A., Stebbing, Martin J.
Publicado em 2014

The Extracellular Domain of Neurotrophin Receptor p75 as a Candidate Biomarker for Amyotrophic Lateral Sclerosis

Por Shepheard, Stephanie R., Chataway, Tim, Schultz, David W., Rush, Robert A., Rogers, Mary-Louise
Publicado em 2014

Non-viral gene therapy that targets motor neurons in vivo

Por Rogers, Mary-Louise, Smith, Kevin S., Matusica, Dusan, Fenech, Matthew, Hoffman, Lee, Rush, Robert A., Voelcker, Nicolas H.
Publicado em 2014

Urinary p75(ECD): A prognostic, disease progression, and pharmacodynamic biomarker in ALS

Por Shepheard, Stephanie R., Wuu, Joanne, Cardoso, Michell, Wiklendt, Luke, Dinning, Phil G., Chataway, Tim, Schultz, David, Benatar, Michael, Rogers, Mary-Louise
Publicado no Neurology (2017)

ProNGF mediates death of Natural Killer cells through activation of the p75NTR-Sortlin complex

Por Rogers, Mary-Louise, Bailey, Sheree, Matusica, Dusan, Nicholson, Ian, Muyderman, Hakan, Pagadala, Promila C, Neet, Kenneth E, Zola, Heddy, Macardle, Peter, Rush, Robert A
Publicado em 2010

Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort

Por Jia, Rui, Shepheard, Stephanie, Jin, Jiaoting, Hu, Fangfang, Zhao, Xing, Xue, Li, Xiang, Li, Qi, Huaguang, Qu, Qiumin, Guo, Feng, Rogers, Mary-Louise, Dang, Jingxia
Publicado no Sci Rep (2017)

The Paradoxical Signals of Two TrkC Receptor Isoforms Supports a Rationale for Novel Therapeutic Strategies in ALS

Por Brahimi, Fouad, Maira, Mario, Barcelona, Pablo F., Galan, Alba, Aboulkassim, Tahar, Teske, Katrina, Rogers, Mary-Louise, Bertram, Lisa, Wang, Jing, Yousefi, Masoud, Rush, Robert, Fabian, Marc, Cashman, Neil, Saragovi, H. Uri
Publicado no PLoS One (2016)